查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941463

治疗诊断学市场规模、份额和趋势分析报告：按放射性同位素、方法、应用、地区和细分市场预测，2026-2033年

Radiotheranostics Market Size, Share & Trends Analysis Report By Radioisotope, By Approach, By Application, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

治疗诊断学市场概述

2025年全球治疗诊断学市场规模估计为117.9亿美元，预计2033年将达到255.6亿美元。

预计从 2026 年到 2033 年，该市场将以 9.5% 的复合年增长率成长。该市场代表了一种精准医疗方法，它将分子影像和标靶放射性核素治疗相结合，以改善患者选择、治疗准确性和长期疗效监测。

透过围绕同一生物标的整合诊断和治疗，治疗诊断学能够降低临床不确定性，支持个人化给药策略，并实现先进肿瘤资源的有效利用。例如，2025年3月，Actinium Pharmaceuticals公司宣布其治疗诊断学产品线取得进展，强调了标靶放射性药物疗法的持续研发。这反映了整个产业向经临床检验的、以标靶驱动的治疗平台发展的趋势。不断扩大的临床证据、监管机构对靶向放射性药物日益增长的认可，以及专科肿瘤和核医学中心的广泛应用，都为市场接受度的提升提供了支持。然而，同位素供应、生产扩充性、基础设施准备以及医保报销等方面的限制因素正在限制该领域的进展。整个生态系统的策略重点包括靶向配体创新、建立长期的同位素供应伙伴关係，以及确保临床环境一致性和合规性的服务交付模式。

目前治疗诊断学市场正经历临床应用范围的稳定扩展和操作复杂性的不断提高。该治疗方法正从早期应用阶段走向更有系统地整合到癌症治疗路径中。研发活动主要集中在提高标靶化精准度、优化放射性核种以及整合先进的影像和剂量测定工具以支援个人化治疗方案的发展。创新不仅限于已有的基于胜肽的放射性配体；抗体片段、设计胜肽和小分子载体方面的投资也在增加，这些技术能够提高肿瘤特异性和治疗指数。同时，α发射体计画的进展正在塑造下一代产品线，以应对抗药性和转移性疾病的挑战。

儘管取得了这些进展，但市场扩张仍然受到许多实际因素的限制，包括治疗场所的同位素供应、生产扩充性、低温运输物流以及基础设施建设。医疗系统正在探索枢纽辐射式供应模式，并与外部放射性药物分发部门合作，以应对复杂性并确保药物的可及性。报销政策的一致性仍然是支付方评估诊断和治疗领域临床价值的关键因素。例如，SHINE Technologies 于 2024 年 10 月宣布的一项合作临床前研究（公司新闻稿）显示，一种新型放射性治疗诊断候选药物在前列腺癌和肾癌模型中展现出令人鼓舞的肿瘤消退效果，这支持了同位素生产和靶向放射性药物开发交叉领域的持续创新。

目录

第一章调查方法和范围

第二章执行摘要

第三章治疗诊断学市场变数、趋势与范围

  • 市场谱系展望
  • 市场动态
  • 商业环境分析
    • 产业分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 专利到期分析
    • 定价分析

第四章治疗诊断学市场：按放射性同位素分類的业务分析

  • 按放射性同位素分類的市场份额，2025 年和 2033 年
  • 市场规模、预测与趋势分析：按放射性同位素划分，2021-2033 年
  • 碘-131
  • 碘-123
  • 镓-68
  • 镏-177
  • 18F・Y90F
  • 其他的

第五章治疗诊断学市场：依方法进行业务分析

  • 按方法分類的市场份额，2025 年和 2033 年
  • 市场规模、预测与趋势分析：按方法划分，2021-2033 年
  • 标靶治疗
  • 标靶诊断

第六章治疗诊断学市场：按应用领域分類的业务分析

  • 按应用领域分類的市场份额，2025 年和 2033 年
  • 市场规模、预测与趋势分析：按应用领域划分，2021-2033年
  • 肿瘤学
  • 非肿瘤科

第七章治疗诊断学市场：区域估算与趋势分析

  • 2025年及2033年区域市占率分析
  • 区域市场概览
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 挪威
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 参与公司概况
  • 企业市场分析
  • 公司分类
  • 策略规划
  • 公司简介/列表
    • Bayer
    • Lantheus Holdings
    • POINT Biopharma
    • Telix Pharmaceuticals
    • Actinium Pharmaceuticals
    • RadioMedix
    • IsoRay
    • SHINE Technologies
    • NorthStar Medical Radioisotopes
    • Fusion Pharmaceuticals
    • Novartis
Product Code: GVR-4-68040-066-7

Radiotheranostics Market Summary

The global radiotheranostics market size was estimated at USD 11.79 billion in 2025 and is projected to reach USD 25.56 billion by 2033, growing at a CAGR of 9.5% from 2026 to 2033. The market represents a precision medicine approach that integrates molecular imaging with targeted radionuclide therapy to enhance patient selection, treatment accuracy, and longitudinal outcome monitoring.

By unifying diagnostics and therapy around the same biological target, radiotheranostics reduces clinical uncertainty, supports individualized dosing strategies, and enables more efficient utilization of advanced oncology resources. For instance, in March 2025, according to Actinium Pharmaceuticals, the company announced progress in its radiotheranostic pipeline, underscoring continued development of targeted radiopharmaceutical therapies, reflecting broader industry momentum toward clinically validated, target-driven treatment platforms. Market adoption is supported by expanding clinical evidence, increasing regulatory acceptance of targeted radiopharmaceuticals, and growing uptake across specialized oncology and nuclear medicine centers, while progression is moderated by constraints related to isotope availability, manufacturing scalability, infrastructure readiness, and reimbursement alignment. Strategic priorities across the ecosystem include innovation in targeting ligands, long-term isotope supply partnerships, and service delivery models that ensure consistent and compliant clinical deployment across care settings.

The current radiotheranostics market scenario is characterized by steady clinical expansion and increasing operational sophistication, as the modality moves from early adoption toward more structured integration within oncology care pathways. Development activity is increasingly focused on improving targeting accuracy, optimizing radionuclide selection, and embedding advanced imaging and dosimetry tools to support personalized treatment planning. Innovation is no longer limited to established peptide based radioligands, with growing investment in antibody fragments, engineered peptides, and small molecule vectors that enhance tumor specificity and therapeutic index. Parallel advances in alpha emitter programs are shaping next generation pipelines aimed at addressing resistant and metastatic disease settings.

Despite this momentum, market progression continues to be moderated by practical constraints related to isotope availability, manufacturing scalability, cold chain logistics, and infrastructure readiness across treatment centers. Health systems are evaluating hub and spoke delivery models and external radiopharmacy partnerships to manage complexity while preserving access. Reimbursement alignment remains a critical factor, as payers assess clinical value across both diagnostic and therapeutic components. For instance, in October 2024, according to SHINE Technologies (company press release), collaborative preclinical research demonstrated promising tumor regression outcomes for novel radiotheranostic candidates in prostate and kidney cancer models, underscoring sustained innovation at the intersection of isotope production and targeted radiopharmaceutical development.

Global Radiotheranostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global radiotheranostics market report based on radioisotope, approach, application, and region:

  • Radioisotope Outlook (Revenue, USD Million, 2021 - 2033)
  • Iodine-131
  • Iodine-123
  • Gallium-68
  • Lutetium-177
  • 18F with Y-90
  • Others
  • Approach Outlook (Revenue, USD Million, 2021 - 2033)
  • Targeted Therapeutic
  • Targeted Diagnostic
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
    • Thyroid Cancer
    • Neuroendocrine Tumor
    • Hepatocellular Carcinoma
    • Prostate Cancer
    • Others
  • Non-Oncology
    • Neurological Disorders
    • Arthritis
    • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Segment Definitions
    • 1.2.1 Radioisotope
    • 1.2.2 Approach
    • 1.2.3 Application
  • 1.3 Estimates and Forecast Timeline
  • 1.4 Research Methodology
  • 1.5 Information Procurement
    • 1.5.1 Purchased Database
    • 1.5.2 GVR's Internal Database
    • 1.5.3 Secondary Sources
    • 1.5.4 Primary Research
  • 1.6 Information Analysis
    • 1.6.1 Data Analysis Models
  • 1.7 Market Formulation & Data Visualization
  • 1.8 Model Details
    • 1.8.1 Commodity Flow Analysis
  • 1.9 List of Secondary Sources
  • 1.10 Objectives

Chapter 2. Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Radiotheranostics Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 Business Environment Analysis
    • 3.3.1 Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1 Supplier Power
      • 3.3.1.2 Buyer Power
      • 3.3.1.3 Substitution Threat
      • 3.3.1.4 Threat of New Entrants
      • 3.3.1.5 Competitive Rivalry
    • 3.3.2 PESTLE Analysis
    • 3.3.3 Pipeline Analysis
    • 3.3.4 Patent Expiry Analysis
    • 3.3.5 Pricing Analysis

Chapter 4. Radiotheranostics Market: Radioisotope Business Analysis

  • 4.1. Radioisotope Market Share, 2025 & 2033
  • 4.2. Radioisotope Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Radioisotope, 2021 to 2033 (USD Million)
  • 4.4. Iodine-131
    • 4.4.1 Iodine-131 Market, 2021 - 2033 (USD Million)
  • 4.5. Iodine-123
    • 4.5.1 Iodine-123 Market, 2021 - 2033 (USD Million)
  • 4.6. Gallium-68
    • 4.6.1 Gallium-68 Market, 2021 - 2033 (USD Million)
  • 4.7. Lutetium-177
    • 4.7.1 Lutetium-177 Market, 2021 - 2033 (USD Million)
  • 4.8. 18F with Y-90
    • 4.8.1 18F with Y-90 Market, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1 Others Market, 2021 - 2033 (USD Million)

Chapter 5. Radiotheranostics Market: Approach Business Analysis

  • 5.1. Approach Market Share, 2025 & 2033
  • 5.2. Approach Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Approach, 2021 to 2033 (USD Million)
  • 5.4. Targeted Therapeutic
    • 5.4.1 Targeted Therapeutic Market, 2021 - 2033 (USD Million)
  • 5.5. Targeted Diagnostic
    • 5.5.1 Targeted Diagnostic Market, 2021 - 2033 (USD Million)

Chapter 6. Radiotheranostics Market: Application Business Analysis

  • 6.1. Application Market Share, 2025 & 2033
  • 6.2. Application Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Oncology
    • 6.4.1 Oncology Market, 2021 - 2033 (USD Million)
      • 6.4.1.1 Thyroid Cancer Market, 2021 - 2033 (USD Million)
      • 6.4.1.2 Neuroendocrine Tumor Market, 2021 - 2033 (USD Million)
      • 6.4.1.3 Hepatocellular Carcinoma Market, 2021 - 2033 (USD Million)
      • 6.4.1.4 Prostate Cancer Market, 2021 - 2033 (USD Million)
      • 6.4.1.5 Others Market, 2021 - 2033 (USD Million)
  • 6.5. Non-Oncology
    • 6.5.1 Non-Oncology Market, 2021 - 2033 (USD Million)
      • 6.5.1.1 Neurological Disorders Market, 2021 - 2033 (USD Million)
      • 6.5.1.2 Arthritis Market, 2021 - 2033 (USD Million)
      • 6.5.1.3 Others Market, 2021 - 2033 (USD Million)

Chapter 7. Radiotheranostics Market: Regional Estimates & Trend Analysis

  • 7.1 Regional Market Share Analysis, 2025 & 2033
  • 7.2 Regional Market Dashboard
  • 7.3 Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4 North America
    • 7.4.1 North America Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
    • 7.4.2 U.S.
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Regulatory Framework
      • 7.4.2.3 Reimbursement Scenario
      • 7.4.2.4 U.S. Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.4.3 Canada
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Regulatory Framework
      • 7.4.3.3 Reimbursement Scenario
      • 7.4.3.4 Canada Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.4.4 Mexico
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Regulatory Framework
      • 7.4.4.3 Reimbursement Scenario
      • 7.4.4.4 Mexico Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
  • 7.5 Europe
    • 7.5.1 Europe Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
    • 7.5.2 UK
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Regulatory Framework
      • 7.5.2.3 Reimbursement Scenario
      • 7.5.2.4 UK Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.5.3 Germany
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Regulatory Framework
      • 7.5.3.3 Reimbursement Scenario
      • 7.5.3.4 Germany Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.5.4 France
      • 7.5.4.1 Key Country Dynamics
      • 7.5.4.2 Regulatory Framework
      • 7.5.4.3 Reimbursement Scenario
      • 7.5.4.4 France Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.5.5 Italy
      • 7.5.5.1 Key Country Dynamics
      • 7.5.5.2 Regulatory Framework
      • 7.5.5.3 Reimbursement Scenario
      • 7.5.5.4 Italy Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.5.6 Spain
      • 7.5.6.1 Key Country Dynamics
      • 7.5.6.2 Regulatory Framework
      • 7.5.6.3 Reimbursement Scenario
      • 7.5.6.4 Spain Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.5.7 Denmark
      • 7.5.7.1 Key Country Dynamics
      • 7.5.7.2 Regulatory Framework
      • 7.5.7.3 Reimbursement Scenario
      • 7.5.7.4 Denmark Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.5.8 Norway
      • 7.5.8.1 Key Country Dynamics
      • 7.5.8.2 Regulatory Framework
      • 7.5.8.3 Reimbursement Scenario
      • 7.5.8.4 Norway Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.5.9 Sweden
      • 7.5.7.1 Key Country Dynamics
      • 7.5.7.2 Regulatory Framework
      • 7.5.7.3 Reimbursement Scenario
      • 7.5.7.4 Sweden Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
  • 7.6 Asia Pacific
    • 7.6.1 Asia Pacific Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
    • 7.6.2 Japan
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 Regulatory Framework
      • 7.6.2.3 Reimbursement Scenario
      • 7.6.2.4 Japan Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.6.3 China
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Regulatory Framework
      • 7.6.3.3 Reimbursement Scenario
      • 7.6.3.4 China Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.6.4 India
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 Regulatory Framework
      • 7.6.4.3 Reimbursement Scenario
      • 7.6.4.4 India Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.6.5 South Korea
      • 7.6.5.1 Key Country Dynamics
      • 7.6.5.2 Regulatory Framework
      • 7.6.5.3 Reimbursement Scenario
      • 7.6.5.4 South Korea Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.6.6 Australia
      • 7.6.6.1 Key Country Dynamics
      • 7.6.6.2 Regulatory Framework
      • 7.6.6.3 Reimbursement Scenario
      • 7.6.6.4 Australia Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.6.7 Thailand
      • 7.6.7.1 Key Country Dynamics
      • 7.6.7.2 Regulatory Framework
      • 7.6.7.3 Reimbursement Scenario
      • 7.6.7.4 Thailand Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
  • 7.7 Latin America
    • 7.7.1 Latin America Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
    • 7.7.2 Brazil
      • 7.7.2.1 Key Country Dynamics
      • 7.7.2.2 Regulatory Framework
      • 7.7.2.3 Reimbursement Scenario
      • 7.7.2.4 Brazil Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.7.3 Argentina
      • 7.7.3.1 Key Country Dynamics
      • 7.7.3.2 Regulatory Framework
      • 7.7.3.3 Reimbursement Scenario
      • 7.7.3.4 Argentina Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
  • 7.8 Middle East & Africa
    • 7.8.1 Middle East & Africa Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
    • 7.8.2 South Africa
      • 7.8.2.1 Key Country Dynamics
      • 7.8.2.2 Regulatory Framework
      • 7.8.2.3 Reimbursement Scenario
      • 7.8.2.4 South Africa Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.8.3 Saudi Arabia
      • 7.8.3.1 Key Country Dynamics
      • 7.8.3.2 Regulatory Framework
      • 7.8.3.3 Reimbursement Scenario
      • 7.8.3.4 Saudi Arabia Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.8.4 UAE
      • 7.8.4.1 Key Country Dynamics
      • 7.8.4.2 Regulatory Framework
      • 7.8.4.3 Reimbursement Scenario
      • 7.8.4.4 UAE Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
    • 7.8.5 Kuwait
      • 7.8.5.1 Key Country Dynamics
      • 7.8.5.2 Regulatory Framework
      • 7.8.5.3 Reimbursement Scenario
      • 7.8.5.4 Kuwait Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1 Bayer
      • 8.5.1.1 Overview
      • 8.5.1.2 Financial Performance
      • 8.5.1.3 Product Benchmarking
      • 8.5.1.4 Strategic Initiatives
    • 8.5.2 Lantheus Holdings
      • 8.5.2.1 Overview
      • 8.5.2.2 Financial Performance
      • 8.5.2.3 Product Benchmarking
      • 8.5.2.4 Strategic Initiatives
    • 8.5.3 POINT Biopharma
      • 8.5.3.1 Overview
      • 8.5.3.2 Financial Performance
      • 8.5.3.3 Product Benchmarking
      • 8.5.3.4 Strategic Initiatives
    • 8.5.4 Telix Pharmaceuticals
      • 8.5.4.1 Overview
      • 8.5.4.2 Financial Performance
      • 8.5.4.3 Product Benchmarking
      • 8.5.4.4 Strategic Initiatives
    • 8.5.5 Actinium Pharmaceuticals
      • 8.5.5.1 Overview
      • 8.5.5.2 Financial Performance
      • 8.5.5.3 Product Benchmarking
      • 8.5.5.4 Strategic Initiatives
    • 8.5.6 RadioMedix
      • 8.5.6.1 Overview
      • 8.5.6.2 Financial Performance
      • 8.5.6.3 Product Benchmarking
      • 8.5.6.4 Strategic Initiatives
    • 8.5.7 IsoRay
      • 8.5.7.1 Overview
      • 8.5.7.2 Financial Performance
      • 8.5.7.3 Product Benchmarking
      • 8.5.7.4 Strategic Initiatives
    • 8.5.8 SHINE Technologies
      • 8.5.8.1 Overview
      • 8.5.8.2 Financial Performance
      • 8.5.8.3 Product Benchmarking
      • 8.5.8.4 Strategic Initiatives
    • 8.5.9 NorthStar Medical Radioisotopes
      • 8.5.9.1 Overview
      • 8.5.9.2 Financial Performance
      • 8.5.9.3 Product Benchmarking
      • 8.5.9.4 Strategic Initiatives
    • 8.5.10 Fusion Pharmaceuticals
      • 8.5.10.1 Overview
      • 8.5.10.2 Financial Performance
      • 8.5.10.3 Product Benchmarking
      • 8.5.10.4 Strategic Initiatives
    • 8.5.11 Novartis
      • 8.5.11.1 Overview
      • 8.5.11.2 Financial Performance
      • 8.5.11.3 Product Benchmarking
      • 8.5.11.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Radiotheranostics Market Market, by Region, 2021 - 2033 (USD Million)
  • Table 4 Global Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 5 Global Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 6 Global Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 7 North America Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 9 North America Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 10 North America Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 11 U.S. Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 12 U.S. Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 13 U.S. Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 14 Canada Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 15 Canada Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 16 Canada Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 17 Mexico Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 18 Mexico Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 19 Mexico Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 20 Europe Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 22 Europe Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 23 Europe Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 24 UK Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 25 UK Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 26 UK Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 27 Germany Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 28 Germany Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 29 Germany Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 30 France Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 31 France Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 32 France Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 33 Italy Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 34 Italy Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 35 Italy Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 36 Spain Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 37 Spain Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 38 Spain Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 39 Denmark Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 40 Denmark Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 41 Denmark Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 42 Norway Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 43 Norway Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 44 Norway Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 45 Sweden Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 46 Sweden Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 47 Sweden Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 52 Japan Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 53 Japan Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 54 Japan Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 55 China Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 56 China Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 57 China Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 58 India Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 59 India Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 60 India Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 61 South Korea Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 62 South Korea Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 63 South Korea Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 64 Australia Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 65 Australia Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 66 Australia Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 67 Thailand Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 68 Thailand Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 69 Thailand Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 70 Latin America Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 72 Latin America Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 73 Latin America Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 74 Brazil Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 75 Brazil Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 76 Brazil Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 77 Argentina Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 78 Argentina Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 79 Argentina Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 84 South Africa Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 85 South Africa Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 86 South Africa Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 90 UAE Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 91 UAE Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 92 UAE Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Radiotheranostics Market: market outlook
  • Fig. 14 Radiotheranostics Market: competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Radiotheranostics Market driver impact
  • Fig. 20 Radiotheranostics Market restraint impact
  • Fig. 21 Radiotheranostics Market strategic initiatives analysis
  • Fig. 22 Radiotheranostics Market: Radioisotope movement analysis
  • Fig. 23 Radiotheranostics Market: Radioisotope outlook and key takeaways
  • Fig. 24 Iodine-131 market estimates and forecast, 2021 - 2033
  • Fig. 25 Iodine-123 market estimates and forecast, 2021 - 2033
  • Fig. 26 Gallium-68 market estimates and forecast, 2021 - 2033
  • Fig. 27 Lutetium-177 market estimates and forecast, 2021 - 2033
  • Fig. 28 18F with Y-90 market estimates and forecast, 2021 - 2033
  • Fig. 29 Others market estimates and forecasts, 2021 - 2033
  • Fig. 30 Radiotheranostics Market: Approach movement analysis
  • Fig. 31 Radiotheranostics Market: Approach outlook and key takeaways
  • Fig. 32 Targeted Therapeutic market estimates and forecast, 2021 - 2033
  • Fig. 33 Targeted Diagnostic market estimates and forecast, 2021 - 2033
  • Fig. 34 Radiotheranostics Market: Application movement analysis
  • Fig. 35 Radiotheranostics Market: Application outlook and key takeaways
  • Fig. 36 Oncology market estimates and forecast, 2021 - 2033
  • Fig. 37 Thyroid Cancer market estimates and forecast, 2021 - 2033
  • Fig. 38 Neuroendocrine Tumor market estimates and forecast, 2021 - 2033
  • Fig. 39 Hepatocellular Carcinoma market estimates and forecast, 2021 - 2033
  • Fig. 40 Prostate Cancer market estimates and forecast, 2021 - 2033
  • Fig. 41 Others market estimates and forecasts, 2021 - 2033
  • Fig. 42 Non-Oncology market estimates and forecast, 2021 - 2033
  • Fig. 43 Neurological Disorders market estimates and forecast, 2021 - 2033
  • Fig. 44 Arthritis market estimates and forecast, 2021 - 2033
  • Fig. 45 Others market estimates and forecasts, 2021 - 2033
  • Fig. 46 Radiotheranostics Market: Regional movement analysis
  • Fig. 47 Radiotheranostics Market: Regional outlook and key takeaways
  • Fig. 48 Radiotheranostics Market share and leading players
  • Fig. 49 North America Radiotheranostics Market share and leading players
  • Fig. 50 Europe Radiotheranostics Market share and leading players
  • Fig. 51 Asia Pacific Radiotheranostics Market share and leading players
  • Fig. 52 Latin America Radiotheranostics Market share and leading players
  • Fig. 53 Middle East & Africa Radiotheranostics Market share and leading players
  • Fig. 54 North America Radiotheranostics Market SWOT Analysis
  • Fig. 55 Europe Radiotheranostics Market SWOT Analysis
  • Fig. 56 Asia Pacific Radiotheranostics Market SWOT Analysis
  • Fig. 57 Latin America Radiotheranostics Market SWOT Analysis
  • Fig. 58 Middle East & Africa Radiotheranostics Market SWOT Analysis
  • Fig. 59 North America Radiotheranostics Market Analysis, by country
  • Fig. 60 North America
  • Fig. 61 North America Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 62 U.S.
  • Fig. 63 U.S. Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 64 Canada
  • Fig. 65 Canada Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 66 Mexico
  • Fig. 67 Mexico Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 68 Europe
  • Fig. 69 Europe Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 70 UK
  • Fig. 71 UK Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 72 Germany
  • Fig. 73 Germany Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 74 France
  • Fig. 75 France Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 76 Italy
  • Fig. 77 Italy Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 78 Spain
  • Fig. 79 Spain Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 80 Denmark
  • Fig. 81 Denmark Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 82 Sweden
  • Fig. 83 Sweden Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 84 Norway
  • Fig. 85 Norway Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 86 Asia Pacific
  • Fig. 87 Asia Pacific Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 88 China
  • Fig. 89 China Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 90 Japan
  • Fig. 91 Japan Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 92 India
  • Fig. 93 India Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 94 Thailand
  • Fig. 95 Thailand Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 96 South Korea
  • Fig. 97 South Korea Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 98 Australia
  • Fig. 99 Australia Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 100 Latin America
  • Fig. 101 Latin America Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 102 Brazil
  • Fig. 103 Brazil Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 104 Argentina
  • Fig. 105 Argentina Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 106 Middle East & Africa
  • Fig. 107 Middle East & Africa Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 108 South Africa
  • Fig. 109 South Africa Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 110 Saudi Arabia
  • Fig. 111 Saudi Arabia Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 112 UAE
  • Fig. 113 UAE Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 114 Kuwait
  • Fig. 115 Kuwait Radiotheranostics Market Estimates and Forecasts 2021 - 2033
  • Fig. 116 Market share of key market players - Radiotheranostics Market